Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience

A systematic and ordered product development program, in compliance with current quality and regulatory standards, increases the likelihood of yielding a successful advanced therapy medicinal product (ATMP) for clinical use as safe and effective therapy. As this is a novel field, little accurate inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Gastelurrutia, Paloma, Prat-Vidal, Cristina, Vives, Joaquim, Coll, Ruth, Bayes-Genis, Antoni, Gálvez-Montón, Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890001/
https://www.ncbi.nlm.nih.gov/pubmed/33614746
http://dx.doi.org/10.3389/fcvm.2021.604434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890001/
https://www.ncbi.nlm.nih.gov/pubmed/33614746
http://dx.doi.org/10.3389/fcvm.2021.604434

Ejemplares similares